The other side of the coin: Socioeconomic analysis of antibiotic resistance;La otra cara de la moneda: Análisis socioeconómico de las resistencias a los antibióticos

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 17, Issue SUPPL. 2, 1999, Pages 27-31

  García Altes, Anna ^a,b   Jovell, Albert J ^a   Aymerich, Marta ^a  

^a Dept de Sanitat i Seguretat Social ^*  (Spain)

^b Catalan Agency for Health Technology Assessment and Research   (Spain)

Author keywords

Antibiotic; Bacterial resistance; Cost analysis; Externality; Review of the scientific evidence

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; BIBLIOMETRICS; CASE MANAGEMENT; COST BENEFIT ANALYSIS; DRUG COST; ECONOMICS; EUROPE; EVIDENCE BASED MEDICINE; HOSPITAL COST; HUMAN; REVIEW; SOCIOECONOMICS;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BIBLIOMETRICS; CASE MANAGEMENT; COST-BENEFIT ANALYSIS; DRUG COSTS; DRUG RESISTANCE, MICROBIAL; EUROPE; EVIDENCE-BASED MEDICINE; HOSPITAL COSTS; HUMANS; SOCIOECONOMIC FACTORS;

EID: 0033252558     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Tomasz A. Multiple-antibiotic-resistant pathogenic bacteria. A report on the Rockefeller University workshop. N Eng J Med 1994; 330: 1247-1251.
2. Krause RM. The origin of plagues: old and new. Science 1992; 257: 1073-1078.
3. Kunin CM. Resistance to antimicrobial drugs -a worldwide calamity. Ann Intern Med 1993; 118: 557-561.
4. Hawkey PM. Action against antibiotic resistance: no time to lose. The Lancet 1998; 351: 1298-1299.
5. Bugs and superbugs. The Economist 1993; April 4th.
6. Aymerich M. Las resistencias bacterianas, un problema de Salud Pública. El Médico, 25 de Septiembre de 1998.
7. Holmberg SD, Solomon SL, Blake PA. Health and economic impacts of antimicrobial resistance. Rev Infect Diseases, 1987; 9 (6) 1065-1078.
8. Phelps CE. Bug/drug resistance. Sometimes less is more. Med Care, 1989; 27 (2): 194-203.
9. Birmingham MC, Hassett JM, Schentag JJ, Paladino JA. Assessing anti-bacterial pharmacoeconomics in the intensive care unit. Pharmacoeconomics 1997; 12 (6): 637-647.